At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 75 target
Drug / intervention
Canola oil +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Immunomodulating Diets With Arginine and Omega-3 Fatty Acids in Renal Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted Oct 24, 2002·Updated Jan 11, 2017
In Brief
A Early Phase 1 clinical trial evaluating Canola oil, Arginine, and 1 other intervention for Kidney Diseases. Completed, enrolled 75 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this study is to develop low risk therapies that will allow improved and lasting survival of donor tissue with minimal suppression of the immune system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Diseases
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2002
Study CompletionApr 2004
TodayJul 2026
First PostedOct 24, 2002
Study CompletionApr 1, 2004
TodayJul 2, 2026
Posted 23.7 years ago
Interventions
Canola oildietary
Argininedietary
Fish oil emulsiondietary